tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MDCX Stock Latest News

Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
Company AnnouncementsMedicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
9d ago
MDCX
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
PremiumCompany Announcements
Medicus Pharma Wins FDA Go-Ahead for Phase 2b Teverelix Trial in High-Risk Prostate Cancer
9d ago
MDCX
Medicus signs six-part media series with New to the Street
PremiumThe Fly
Medicus signs six-part media series with New to the Street
9d ago
MDCX
Medicus receives FDA ‘study may proceed’ clearance for Teverelix Phase 2b study
PremiumThe Fly
Medicus receives FDA ‘study may proceed’ clearance for Teverelix Phase 2b study
9d ago
MDCX
Medicus Pharma Lowers Teverelix Royalty Burden in Amended LifeArc License
PremiumCompany Announcements
Medicus Pharma Lowers Teverelix Royalty Burden in Amended LifeArc License
28d ago
MDCX
Medicus announces amendment to LifeArc license improving Teverelix profile
PremiumThe FlyMedicus announces amendment to LifeArc license improving Teverelix profile
28d ago
MDCX
Medicus Pharma Highlights Positive Teverelix Phase 1 Data and Near-Term SkinJect Milestones
Premium
Company Announcements
Medicus Pharma Highlights Positive Teverelix Phase 1 Data and Near-Term SkinJect Milestones
1M ago
MDCX
Medicus Pharma announces clinical data on Teverelix
Premium
The Fly
Medicus Pharma announces clinical data on Teverelix
1M ago
MDCX
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears
PremiumCompany Announcements
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears
2M ago
MDCX
Medicus Pharma Launches At-the-Market Equity Offering Program
PremiumCompany Announcements
Medicus Pharma Launches At-the-Market Equity Offering Program
2M ago
8K
MDCX
Medicus Pharma Taps Reliant AI for Data-Driven Teverelix Clinical Development
PremiumCompany Announcements
Medicus Pharma Taps Reliant AI for Data-Driven Teverelix Clinical Development
2M ago
MDCX
Medicus Pharma enters non-binding LOI with Reliant AI
PremiumThe Fly
Medicus Pharma enters non-binding LOI with Reliant AI
2M ago
MDCX
Medicus Pharma Completes Patient Enrollment for Phase 2 BCC Treatment Study
PremiumCompany AnnouncementsMedicus Pharma Completes Patient Enrollment for Phase 2 BCC Treatment Study
2M ago
MDCX
Medicus Pharma completes enrollment of 90 patients for Phase 2 study
Premium
The Fly
Medicus Pharma completes enrollment of 90 patients for Phase 2 study
2M ago
MDCX
Medicus Pharma’s Warrant Inducement Agreement Announced
Premium
Company Announcements
Medicus Pharma’s Warrant Inducement Agreement Announced
2M ago
8K
MDCX
Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials
PremiumCompany Announcements
Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials
3M ago
MDCX
Medicus Pharma appoints Carolyn Bonner as CFO
PremiumThe Fly
Medicus Pharma appoints Carolyn Bonner as CFO
3M ago
MDCX
Medicus Pharma explores novel treatment innovations for prostate, skin cancers
PremiumThe Fly
Medicus Pharma explores novel treatment innovations for prostate, skin cancers
3M ago
MDCX
Medicus Pharma files to sell 2.68M common shares for holders
PremiumThe Fly
Medicus Pharma files to sell 2.68M common shares for holders
3M ago
MDCX
Is MDCX a Buy, Before Earnings?
PremiumPre-EarningsIs MDCX a Buy, Before Earnings?
3M ago
MDCX
Optimistic Buy Rating for Medicus Pharma Ltd Driven by Promising SkinJect Developments and Strategic Initiatives
Premium
Ratings
Optimistic Buy Rating for Medicus Pharma Ltd Driven by Promising SkinJect Developments and Strategic Initiatives
3M ago
MDCX
Medicus Pharma Seeks FDA Priority Voucher for Innovative Skin Cancer Treatment
Premium
Company Announcements
Medicus Pharma Seeks FDA Priority Voucher for Innovative Skin Cancer Treatment
3M ago
MDCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >